The deviated management of preeclampsia with severe features at Maharat Nakhon Ratchasima Hospital
Main Article Content
Abstract
Objectives: To study the prevalence and causes of deviated management of preeclampsia with severe features and to study the complications of preeclampsia with severe features at Maharat Nakhon Ratchasima Hospital (MNRH). Patients and Methods: This retrospective descriptive study collected data from referral letters and medical records of preeclampsia with severe features and eclampsia at MNRH diagnosed and treated between 1 December 2014 and 31 October 2015. The standard management guidelines include antihypertensive treatment, MgSO4 for convulsion prevention, termination of pregnancy; and prevention of complication. The patients were categorized into 2 groups whether there was deviated management or not. The data of two groups were expressed as percentage and compared using the Chi-Square test and if p-value was < 0.05, it would be considered statistically significant. Results: Among 186 patients with diagnosis of preeclampsia with severe features and eclampsia, deviated management was found in 154 patients (81.7 %). The top-three common deviated managements were the subtherapeutic level of MgSO4 before delivery (61.2 %), delayed increment of MgSO4 despite subtherapeutic level (50.7 %) and delayed laboratory test results (46.1 %). In deviated management group, 84.4 % had BMI >25 kg/m2 that were significantly more than those of the usual management group. However, the pregnancy outcomes and complications among two groups were not different. Conclusion: The deviated management was found in more than 80 % of preeclampsia with severe features and eclampsia at MNRH but no serious sequelae were seen.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
American College of Obstetricians and Gynecologists: Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol 2013; 122: 1122-31.
Cunningham FG, Leveno KJ, Bloom SL, Hauth JC, Rouse DJ, Spong CY, et al. Hypertensive disorders in pregnancy. In: Williams Obstetrics. 24th ed. New York: McGraw-Hill; 2014; 728.
ราชวิทยาลัยสูตินรีแพทย์แห่งประเทศไทย. RTCOG Clinical Practice Guldeline Management of Preeclampsia and Eclampsia; สิงหาคม 2558: 60-76.
Kitiyodom S. Eclampsia in Maharat Nakhon Ratchasima Hospital. Med J Srisaket Surin Buriram Hospitals 2014; 29: 129-38.
Boonyongchaisawad R. Association between maternal body mass index and subtherapeutic serum magnesium level in severe preeclampsia at Maharat Nakhon Ratchasima Hospital. Thai J Obstet Gynaecol 2559; 24: 145-52.
Jaisamut P. Effect of maternal body mass index on serum magnesium level given for severe preeclampsia at Maharat Nakhon Ratchasima Hospital. Thai J Obstet Gynecol 2560; 25: 159-66.
Kitiyodom S. Comparison of the level of magnesium during maintenance between 2 gram and 1 gram per hour infusion in overweight mothers with preeclampsia. J Med Assoc Thai 2016; 99 suppl 7: S133-7.
ACOG. Committee on Practice Bulletins-Obstetrics. Diagnosis and management of preeclampsia and eclampsia. Obstet Gynecol. 2001; 98: 159-67.
Sibai BM, Stella CL. Diagnosis and management of atypical preeclampsia-eclampsia. Am J Obstet Gynecol 2009; 200: 481.e1-7.
Sabai BM. Pitfalls in diagnosis and management of preeclampsia. Am J Obstet Gynecol 1988; 159: 1-5.
Dayicioglu V, Sahinoglu Z, Kol E, Kucukbas M. The use of standard dose of magnesium sulfate in prophylaxis of eclamptic seizures: do body mass index alterations have any effect on success? Hypertens Pregnancy 2003; 22: 257-65.
Charoenvidhya D, Manotaya S. Magnesium sulfate maintenance infusion in women with preeclampsia: a randomized comparison between 2 gram per hour and 1 gram per hour. J Med Assoc Thai 2013; 96: 395-8
Khan A, Ghosh A, Banerjee PK, Kumar T. Analysis of the causes of maternal death in eclampsia, Int Org Sci Res J Dental Med Sci 2014; 13: 7-10.
Ghulmiyyah L, Sibai BM. Maternal mortality from preeclampsia/eclampsia. Semin Perinatol 2012; 36: 56-9.